Inhibiting microglia-derived IL-1β in neovascular AMD could provide therapeutic benefit, preventing further neovascularization in advanced patients, or even preventing neovascularization before it begins in patients with earlier stages of disease. The gene discussed is IL1B; the disease is age-related macular degeneration.